Current advances in microbial-based cancer therapies

Shahbaz, Areej; Mahmood, Tehreem; Javed, Muhammad Uzair; Abbasi, Bilal Haider

doi:10.1007/s12032-023-02074-x

Cited by 4 publications

(1 citation statement)

References 160 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specific gut bacteria have been associated with improved or reduced responses to immunotherapy drugs, highlighting the potential for manipulating the microbiome to enhance treatment outcomes in cancer patients [217,218]. This emerging field of research, known as microbial oncology, holds promise for revolutionizing cancer treatment strategies and improving patient outcomes [219][220][221].…”

Section: Impact Of Microbiome On Treatment Outcomesmentioning

confidence: 99%

Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases

Kamel,

Aleya,

Alsubih

et al. 2024

JPM

View full text Add to dashboard Cite

Infectious diseases have long posed a significant threat to global health and require constant innovation in treatment approaches. However, recent groundbreaking research has shed light on a previously overlooked player in the pathogenesis of disease—the human microbiome. This review article addresses the intricate relationship between the microbiome and infectious diseases and unravels its role as a crucial mediator of host–pathogen interactions. We explore the remarkable potential of harnessing this dynamic ecosystem to develop innovative treatment strategies that could revolutionize the management of infectious diseases. By exploring the latest advances and emerging trends, this review aims to provide a new perspective on combating infectious diseases by targeting the microbiome.

show abstract